Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large-scale multi-sequence pretraining for generalizable MRI analysis in versatile clinical applications.

Nature biomedical engineering·2026
Same author

Thermodynamically programmed one-pot CRISPR platform for point-of-care SNP genotyping.

Nature communications·2026
Same author

A universal foundation model for grounded biomedical image interpretation.

Nature communications·2026
Same author

OECT-Based Real-Time Monitoring of Biofilms Enabling Online Evaluation of Antibiofilm Agents in Flow Culture.

ACS sensors·2026
Same author

Multimodal deep learning model for AI-based functional prognostic risk stratification in patients undergoing radical nephrectomy.

Nature communications·2026
Same author

Author Correction: DNA-guided CRISPR-Cas12a effectors for programmable RNA recognition and cleavage.

Nature biotechnology·2026

Related Experiment Video

Updated: Jan 7, 2026

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

15.6K

Structure-enhanced deep learning accelerates aptamer selection for small molecule families like steroids.

Zibin Zhao1, Haosi Lin1, Hoi Ying Lau1

  • 1Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR 999077, China.

Briefings in Bioinformatics
|December 22, 2025
PubMed
Summary

Deep Learning-assisted SELEX (DL-SELEX) accelerates aptamer discovery by using variational autoencoders (VAEs) to design initial libraries and analyze results. This novel method significantly enhances aptamer affinity and reduces selection steps for challenging small molecules.

Keywords:
SELEXdeep learningisothermal titration calorimetrysmall moleculessteroid aptamersvariational autoencoder

More Related Videos

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
15:23

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on: May 13, 2010

19.9K
Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor
09:33

Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor

Published on: March 21, 2018

10.3K

Related Experiment Videos

Last Updated: Jan 7, 2026

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

15.6K
Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
15:23

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on: May 13, 2010

19.9K
Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor
09:33

Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor

Published on: March 21, 2018

10.3K

Area of Science:

  • Biotechnology
  • Computational Biology
  • Molecular Biology

Background:

  • Systematic Evolution of Ligands by EXponential enrichment (SELEX) is crucial for discovering high-affinity aptamers.
  • Designing initial aptamer libraries and navigating vast sequence spaces are key challenges in SELEX.
  • Current SELEX methods face limitations in efficiency and rational design for small-molecule aptamers.

Purpose of the Study:

  • To introduce Deep Learning-assisted SELEX (DL-SELEX), a novel framework to enhance small-molecule aptamer discovery.
  • To integrate deep learning for rational design of initial aptamer libraries and refine selection processes.
  • To demonstrate the generalizability of DL-SELEX for structurally similar targets.

Main Methods:

  • Developed a two-step framework, DL-SELEX, utilizing variational autoencoders (VAEs).
  • Employed AptaVAE for tailored initial aptamer pool generation using transfer learning.
  • Utilized AptaClux to identify high-performance aptamers from next-generation sequencing data by capturing consensus structural features.

Main Results:

  • DL-SELEX yielded aptamers with up to 450-fold higher affinity for hydrocortisone and testosterone.
  • Reduced the number of SELEX iterations by up to 80%.
  • Demonstrated that deep learning models can be trained on structural commonalities for aptamer design.

Conclusions:

  • DL-SELEX offers an effective and generalizable strategy to streamline aptamer discovery.
  • This approach enables the de novo design of high-affinity aptamers for challenging small molecules.
  • The integration of deep learning significantly advances SELEX workflows for small-molecule aptamer selection.